108 related articles for article (PubMed ID: 386322)
21. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
[TBL] [Abstract][Full Text] [Related]
22. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
[No Abstract] [Full Text] [Related]
23. The impact of low donor-specific MLR versus HLA-DR compatibility on kidney graft survival.
Langhoff E; Jakobsen BK; Platz P; Ryder LP; Svejgaard A
Transplantation; 1985 Jan; 39(1):18-21. PubMed ID: 2578235
[TBL] [Abstract][Full Text] [Related]
24. Cellular and humoral immunity after clinical renal transplantation.
Arnesen E; Bondevik H; Thorsby E
Proc Eur Dial Transplant Assoc; 1975; 11():343-50. PubMed ID: 1105555
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry.
Cook DJ; Fettouh HI; Gjertson DW; Cecka JM
Clin Transpl; 1998; ():413-9. PubMed ID: 10503119
[TBL] [Abstract][Full Text] [Related]
26. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS
Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224
[No Abstract] [Full Text] [Related]
27. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
[TBL] [Abstract][Full Text] [Related]
28. The UNOS renal transplant registry.
Cecka JM
Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
[TBL] [Abstract][Full Text] [Related]
29. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
Nunez G; McPhaul J; Stastny P
Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
[TBL] [Abstract][Full Text] [Related]
30. Outcome of donor specific transfusion renal transplants across B cell positive crossmatches.
Balakrishnan K; Munda R; First MR; Alexander JW
Transplant Proc; 1989 Feb; 21(1 Pt 2):1836. PubMed ID: 2652597
[No Abstract] [Full Text] [Related]
31. T-cell flow-cytometry crossmatch and long-term renal graft survival.
Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
[TBL] [Abstract][Full Text] [Related]
32. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
33. The effect of peak and current serum panel-reactive antibody on graft survival.
Premasathian N; Panorchan K; Vongwiwatana A; Pornpong C; Agadmeck S; Vejbaesya S
Transplant Proc; 2008 Sep; 40(7):2200-1. PubMed ID: 18790191
[TBL] [Abstract][Full Text] [Related]
34. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
[No Abstract] [Full Text] [Related]
35. Kidney transplantation in the United States.
Cecka JM
Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
[TBL] [Abstract][Full Text] [Related]
36. Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients.
Thomas J; Johns C; Hoffmann S; Thomas F; Lee HM
Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():87-9. PubMed ID: 158755
[No Abstract] [Full Text] [Related]
37. Sensitization and crossmatching in renal transplantation.
Koka P; Cecka JM
Clin Transpl; 1989; ():379-90. PubMed ID: 2487606
[TBL] [Abstract][Full Text] [Related]
38. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to donor B lymphocytes and autoantibodies in renal transplantation.
Ettenger RB; Robinson BJ; Uittenbogaart CH; Hacker TA; Pennisi AJ; Malekzadeh MH; Fine RN
Transplant Proc; 1979 Mar; 11(1):401-3. PubMed ID: 377666
[TBL] [Abstract][Full Text] [Related]
40. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
Creemers P; Brink J; Kahn D
Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
